The Safety of Cataract Removal by Phacoemulsification Surgery in Patients Under Anti-aggregant and Coumadin Treatment
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00564356|
Recruitment Status : Unknown
Verified July 2009 by Sheba Medical Center.
Recruitment status was: Recruiting
First Posted : November 27, 2007
Last Update Posted : July 21, 2009
To assess the risks of intra- and postoperative bleeding tendency associated with cataract surgery by phacoemulsification in patients on coumadin and antiaggregant treatments.
Design: Consecutive prospective study.
|Condition or disease||Intervention/treatment|
|Efficacy Complications||Procedure: cataract surgery with phacoemulsification|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||75 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||The Safety of Cataract Removal by Phacoemulsification Surgery in Patients Under Anti-aggregant and Coumadin Treatment|
|Study Start Date :||July 2007|
|Primary Completion Date :||August 2008|
|Estimated Study Completion Date :||December 2010|
patients under coumadin and antiaggregants operated by phacoemulsification
Procedure: cataract surgery with phacoemulsification
removal of cataract with phacoemulsification technique
- safety and efficacy of cataract surgery with phacoemulsification under coumadin and antiaggregant treatment [ Time Frame: 3.5 years ]
- other complications [ Time Frame: 3.5 years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00564356
|Contact: Ophira Salomon, MDemail@example.com|
|Contact: Yael Wasserzug, MDfirstname.lastname@example.org|
|Sheba Medical Center||Recruiting|
|Sub-Investigator: Irina Barequet, md|
|Sub-Investigator: Joseph Moisseiev, MD|
|Study Director:||Ophira Salomon||Sheba Medical Center|